Find Research outputs

Search results

• A Phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer

  Ghamande, S. A., Silverman, M. & Gold, M., Jul 2009, In: Gynecologic Oncology. 114, 1, p. 137 1 p.

  Research output: Contribution to journal › Letter › peer-review
  1 Scopus citations

• A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous Å6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer

  Ghamande, S. A., Silverman, M. H., Huh, W., Behbakht, K., Ball, G., Cuasay, L., Würtz, S. O., Brunner, N. & Gold, M. A., Oct 2008, In: Gynecologic Oncology. 111, 1, p. 89-94 6 p.

  Research output: Contribution to journal › Article › peer-review
  39 Scopus citations

• A Phase 2a dose-escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS-986231 in hospitalized patients with heart failure with reduced ejection fraction

  Tita, C., Gilbert, E. M., Van Bakel, A. B., Grzybowski, J., Haas, G. J., Jarrah, M., Dunlap, S. H., Gottlieb, S. S., Klapholz, M., Patel, P. C., Pfister, R., Seidler, T., Shah, K. B., Zieliński, T., Venuti, R. P., Cowart, D., Foo, S. Y., Vishnevsky, A. & Mitrovic, V., Oct 2017, In: European Journal of Heart Failure. 19, 10, p. 1321-1332 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  41 Scopus citations

• A phase 2 study of MK-0457 in patients with BCR-ABL T315I mutant chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia

  Seymour, J. F., Kim, D. W., Rubin, E., Haregewoin, A., Clark, J., Watson, P., Hughes, T., Dufva, I., Jimenez, J. L., Mahon, F. X., Rousselot, P., Cortes, J., Martinelli, G., Papayannidis, C., Nagler, A. & Giles, F. J., Aug 2014, In: Blood Cancer Journal. 4, 8, e238.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  54 Scopus citations

• A phase 2 study of oxaliplatin combined with continuous infusion topotecan for patients with previously treated ovarian cancer

  Stein, S. M., Tiersten, A., Hochster, H. S., Blank, S. V., Pothuri, B., Curtin, J., Shapira, I., Levinson, B., Ivy, P., Joseph, B., Guddati, A. K. & Muggia, F., 2013, In: International Journal of Gynecological Cancer. 23, 9, p. 1577-1582 6 p.

  Research output: Contribution to journal › Article › peer-review
  11 Scopus citations

• A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis

  Masarova, L., Verstovsek, S., Hidalgo-Lopez, J. E., Pemmaraju, N., Bose, P., Estrov, Z., Jabbour, E. J., Ravandi-Kashani, F., Takahashi, K., Cortes, J. E., Ning, J., Ohanian, M., Alvarado, Y., Zhou, L., Pierce, S., Gergis, R., Patel, K. P., Luthra, R., Kadia, T. M., DiNardo, C. D., & 6 othersBorthakur, G., Bhalla, K., Garcia-Manero, G., Bueso-Ramos, C. E., Kantarjian, H. M. & Daver, N., Oct 18 2018, In: Blood. 132, 16, p. 1664-1674 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  46 Scopus citations

• A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias

  Cortes, J. E., Kim, D. W., Pinilla-Ibarz, J., Le Coutre, P., Paquette, R., Chuah, C., Nicolini, F. E., Apperley, J. F., Khoury, H. J., Talpaz, M., DiPersio, J., DeAngelo, D. J., Abruzzese, E., Rea, D., Baccarani, M., Müller, M. C., Gambacorti-Passerini, C., Wong, S., Lustgarten, S., Rivera, V. M., & 10 othersClackson, T., Turner, C. D., Haluska, F. G., Guilhot, F., Deininger, M. W., Hochhaus, A., Hughes, T., Goldman, J. M., Shah, N. P. & Kantarjian, H., 2013, In: New England Journal of Medicine. 369, 19, p. 1783-1796 14 p.

  Research output: Contribution to journal › Article › peer-review
  810 Scopus citations

• A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs

  Réa, D., Mauro, M. J., Boquimpani, C., Minami, Y., Lomaia, E., Voloshin, S., Turkina, A., Kim, D. W., Apperley, J. F., Abdo, A., Fogliatto, L. M., Kim, D. D. H., le Coutre, P., Saussele, S., Annunziata, M., Hughes, T. P., Chaudhri, N., Sasaki, K., Chee, L., García-Gutiérrez, V., & 6 othersCortes, J. E., Aimone, P., Allepuz, A., Quenet, S., Bédoucha, V. & Hochhaus, A., Nov 25 2021, In: Blood. 138, 21, p. 2031-2041 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  69 Scopus citations

• A phase 3 trial of L-Glutamine in sickle cell disease

  Kumar Guddati, A. & Vamsi Kota, K., Nov 8 2018, In: New England Journal of Medicine. 379, 19, p. 1879 1 p.

  Research output: Contribution to journal › Letter › peer-review
  18 Scopus citations

• A phase I, open-label, multi-center study of the JAK2 inhibitor AZD1480 in patients with myelofibrosis

  Verstovsek, S., Hoffman, R., Mascarenhas, J., Soria, J. C., Bahleda, R., McCoon, P., Tang, W., Cortes, J., Kantarjian, H. & Ribrag, V., Feb 1 2015, In: Leukemia Research. 39, 2, p. 157-163 7 p.

  Research output: Contribution to journal › Article › peer-review
  25 Scopus citations

• A phase I/II randomized trial of clofarabine or fludarabine added to idarubicin and cytarabine for adults with relapsed or refractory acute myeloid leukemia

  Short, N. J., Kantarjian, H., Ravandi, F., Huang, X., Xiao, L., Garcia-Manero, G., Plunkett, W., Gandhi, V., Sasaki, K., Pemmaraju, N., Daver, N. G., Borthakur, G., Jain, N., Konopleva, M., Estrov, Z., Kadia, T. M., Wierda, W. G., DiNardo, C. D., Brandt, M., O’Brien, S. M., & 2 othersCortes, J. E. & Jabbour, E., Jul 19 2018, In: Leukemia and Lymphoma. 59, 4, p. 813-820 8 p.

  Research output: Contribution to journal › Article › peer-review
  13 Scopus citations

• A phase I/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome

  Swaminathan, M., Kantarjian, H. M., Levis, M., Guerra, V., Borthakur, G., Alvarado, Y., DiNardo, C. D., Kadia, T., Garcia-Manero, G., Ohanian, M., Daver, N., Konopleva, M., Pemmaraju, N., Ferrajol, A., Andreeff, M., Jain, N., Estrov, Z., Jabbour, E. J., Wierda, W. G., Pierce, S., & 4 othersPinsoy, M. R., Xiao, L., Ravandi, F. & Cortes, J. E., Aug 2021, In: Haematologica. 106, 8, p. 2121-2130 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  25 Scopus citations

• A phase I/II study of the Janus kinase (JAK)1 and 2 inhibitor ruxolitinib in patients with relapsed or refractory acute myeloid leukemia

  Pemmaraju, N., Kantarjian, H., Kadia, T., Cortes, J., Borthakur, G., Newberry, K., Garcia-Manero, G., Ravandi, F., Jabbour, E., Dellasala, S., Pierce, S. & Verstovsek, S., Mar 1 2015, In: Clinical Lymphoma, Myeloma and Leukemia. 15, 3, p. 171-176 6 p.

  Research output: Contribution to journal › Article › peer-review
  61 Scopus citations

• A phase I/II study of the mTOR inhibitor everolimus in combination with hyperCVAD chemotherapy in patients with relapsed/refractory acute lymphoblastic leukemia

  Daver, N., Boumber, Y., Kantarjian, H., Ravandi, F., Cortes, J., Rytting, M. E., Kawedia, J. D., Basnett, J., Culotta, K. S., Zeng, Z., Lu, H., Richie, M. A., Garris, R., Xiao, L., Liu, W., Baggerly, K. A., Jabbour, E., O'Brien, S., Burger, J., Bendall, L. J., & 2 othersThomas, D. & Konopleva, M., Jun 15 2015, In: Clinical Cancer Research. 21, 12, p. 2704-2714 11 p.

  Research output: Contribution to journal › Article › peer-review
  41 Scopus citations

• A phase i and pharmacodynamic study of AT9283, a small-molecule inhibitor of aurora kinases in patients with relapsed/refractory leukemia or myelofibrosis

  Foran, J., Ravandi, F., Wierda, W., Garcia-Manero, G., Verstovsek, S., Kadia, T., Burger, J., Yule, M., Langford, G., Lyons, J., Ayrton, J., Lock, V., Borthakur, G., Cortes, J. & Kantarjian, H., Jun 2014, In: Clinical Lymphoma, Myeloma and Leukemia. 14, 3, p. 223-230 8 p.

  Research output: Contribution to journal › Article › peer-review
  32 Scopus citations

• A Phase I and Pharmacokinetic Study of VNP40101M, a Novel Sulfonylhydrazine Alkylating Agent, in Patients with Refractory Leukemia

  Giles, F. J., Thomas, D., Garcia-Manero, G., Faderl, S., Cortes, J., Verstovsek, S., Ferrajoli, A., Jeha, S., Beran, M., Koller, C., Andreeff, M., Cahill, A., Clairmont, C., Sznol, M. & Kantarjian, H., May 1 2004, In: Clinical Cancer Research. 10, 9, p. 2908-2917 10 p.

  Research output: Contribution to journal › Article › peer-review
  48 Scopus citations

• A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemia

  Stock, W., Undevia, S. D., Bivins, C., Ravandi, F., Odenike, O., Faderl, S., Rich, E., Borthakur, G., Godley, L., Verstovsek, S., Artz, A., Wierda, W., Larson, R. A., Zhang, Y., Cortes, J., Ratain, M. J. & Giles, F. J., Aug 2008, In: Investigational New Drugs. 26, 4, p. 331-338 8 p.

  Research output: Contribution to journal › Article › peer-review
  9 Scopus citations

• A Phase Ib Study of the Dual PI3K/mTOR Inhibitor Dactolisib (BEZ235) Combined with Everolimus in Patients with Advanced Solid Malignancies

  Wise-Draper, T. M., Moorthy, G., Salkeni, M. A., Karim, N. A., Thomas, H. E., Mercer, C. A., Beg, M. S., O’Gara, S., Olowokure, O., Fathallah, H., Kozma, S. C., Thomas, G., Rixe, O., Desai, P. & Morris, J. C., Jun 1 2017, In: Targeted Oncology. 12, 3, p. 323-332 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  65 Scopus citations

• A phase I clinical trial of flavone-8-acetic acid in combination with interleukin 2

  Holmlund, J. T., Kopp, W. C., Wiltrout, R. H., Longo, D. L., Urba, W. J., Janik, J. E., Sznol, M., Conlon, K. C., Fenton, R. G., Hornung, R., Madara, K., Shields, M. A., Smith, J. W., Sharfman, W., Steis, R. G., Ewel, C., Malspeis, L. & Creekmore, S. P., Jan 18 1995, In: Journal of the National Cancer Institute. 87, 2, p. 134-136 3 p.

  Research output: Contribution to journal › Comment/debate › peer-review
  7 Scopus citations

• A phase i clinical trial of guadecitabine and carboplatin in platinum-resistant, recurrent ovarian cancer: Clinical, pharmacokinetic, and pharmacodynamic analyses

  Matei, D., Ghamande, S., Roman, L., Secord, A. A., Nemunaitis, J., Markham, M. J., Nephew, K. P., Jueliger, S., Oganesian, A., Naim, S., Su, X. Y., Keer, H., Azab, M. & Fleming, G. F., May 15 2018, In: Clinical Cancer Research. 24, 10, p. 2285-2293 9 p.

  Research output: Contribution to journal › Article › peer-review
  40 Scopus citations

• A phase II, single-blind, randomized, crossover evaluation of the safety and efficacy of avanafil using visual sexual stimulation in patients with mild to moderate erectile dysfunction

  Hellstrom, W. J. G., Freier, M. T., Serefoglu, E. C., Lewis, R. W., Didonato, K. & Peterson, C. A., Jan 2013, In: BJU International. 111, 1, p. 137-147 11 p.

  Research output: Contribution to journal › Article › peer-review
  27 Scopus citations

• A phase IIa randomized controlled clinical and histological pilot study evaluating rhGDF-5/β-TCP for periodontal regeneration

  Stavropoulos, A., Windisch, P., Gera, I., Capsius, B., Sculean, A. & Wikesjö, U. M. E., Nov 1 2011, In: Journal of Clinical Periodontology. 38, 11, p. 1044-1054 11 p.

  Research output: Contribution to journal › Article › peer-review
  46 Scopus citations

• A phase IIa randomized controlled pilot study evaluating the safety and clinical outcomes following the use of rhGDF-5/β-TCP in regenerative periodontal therapy

  Windisch, P., Stavropoulos, A., Molnár, B., Szendröi-Kiss, D., Szilágyi, E., Rosta, P., Horváth, A., Capsius, B., Wikesjö, U. M. E. & Sculean, A., Aug 2012, In: Clinical oral investigations. 16, 4, p. 1181-1189 9 p.

  Research output: Contribution to journal › Article › peer-review
  20 Scopus citations

• A phase II clinical trial of a natural formulation containing tea catechins for xerostomia

  De Rossi, S. S., Thoppay, J., Dickinson, D. P., Looney, S., Stuart, M., Ogbureke, K. U. E. & Hsu, S., Oct 1 2014, In: Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 118, 4, p. 447-454.e3

  Research output: Contribution to journal › Article › peer-review
  9 Scopus citations

• A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study

  Chan, J. K., Deng, W., Higgins, R. V., Tewari, K. S., Bonebrake, A. J., Hicks, M., Gaillard, S., Ramirez, P. T., Chafe, W., Monk, B. J. & Aghajanian, C., Sep 2017, In: Gynecologic Oncology. 146, 3, p. 554-559 6 p.

  Research output: Contribution to journal › Article › peer-review
  13 Scopus citations

• A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: A Gynecologic Oncology Group study

  Leslie, K. K., Sill, M. W., Fischer, E., Darcy, K. M., Mannel, R. S., Tewari, K. S., Hanjani, P., Wilken, J. A., Baron, A. T., Godwin, A. K., Schilder, R. J., Singh, M. & Maihle, N. J., Jun 2013, In: Gynecologic Oncology. 129, 3, p. 486-494 9 p.

  Research output: Contribution to journal › Article › peer-review
  54 Scopus citations

• A phase II evaluation of pemetrexed (Alimta, LY231514, IND #40061) in the treatment of recurrent or persistent endometrial carcinoma: A phase II study of the Gynecologic Oncology

  Miller, D. S., Blessing, J. A., Drake, R. D., Higgins, R., McMeekin, D. S., Puneky, L. V. & Krasner, C. N., Dec 2009, In: Gynecologic Oncology. 115, 3, p. 443-446 4 p.

  Research output: Contribution to journal › Article › peer-review
  34 Scopus citations

• A phase I-II trial of fludarabine, bendamustine and rituximab (FBR) in previously treated patients with CLL

  Jain, N., Balakrishnan, K., Ferrajoli, A., O'Brien, S. M., Burger, J. A., Kadia, T. M., Cortes, J. E., Ayres, M. L., Tambaro, F. P., Keating, M. J., Gandhi, V. & Wierda, W. G., 2017, In: Oncotarget. 8, 13, p. 22104-22112 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  5 Scopus citations

• A phase II open-label study of the intravenous administration of homoharringtonine in the treatment of myelodysplastic syndrome

  Daver, N., Vega-Ruiz, A., Kantarjian, H. M., Estrov, Z., Ferrajoli, A., Kornblau, S., Verstovsek, S., Garcia-Manero, G. & Cortes, J. E., Sep 2013, In: European Journal of Cancer Care. 22, 5, p. 605-611 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  11 Scopus citations

• A phase II study of 5-azacitidine for patients with primary and post-essential thrombocythemia/polycythemia vera myelofibrosis

  Quintás-Cardama, A., Tong, W., Kantarjian, H., Thomas, D., Ravandi, F., Kornblau, S., Manshouri, T., Cortes, J. E., Garcia-Manero, G. & Verstovsek, S., May 2008, In: Leukemia. 22, 5, p. 965-970 6 p.

  Research output: Contribution to journal › Article › peer-review
  102 Scopus citations

• A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia Patients

  Tsai, H. J., Jiang, S. S., Hung, W. C., Borthakur, G., Lin, S. F., Pemmaraju, N., Jabbour, E., Bomalaski, J. S., Chen, Y. P., Hsiao, H. H., Wang, M. C., Kuo, C. Y., Chang, H., Yeh, S. P., Cortes, J., Chen, L. T. & Chen, T. Y., Dec 1 2017, In: Scientific reports. 7, 1, 11253.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  45 Scopus citations

• A Phase II Study of Coltuximab Ravtansine (SAR3419) Monotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia

  Kantarjian, H. M., Lioure, B., Kim, S. K., Atallah, E., Leguay, T., Kelly, K., Marolleau, J. P., Escoffre-Barbe, M., Thomas, X. G., Cortes, J., Jabbour, E., O'Brien, S., Bories, P., Oprea, C., Hatteville, L. & Dombret, H., Mar 1 2016, In: Clinical Lymphoma, Myeloma and Leukemia. 16, 3, p. 139-145 7 p.

  Research output: Contribution to journal › Article › peer-review
  50 Scopus citations

• A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome

  Daver, N., Kantarjian, H., Ravandi, F., Estey, E., Wang, X., Garcia-Manero, G., Jabbour, E., Konopleva, M., O'Brien, S., Verstovsek, S., Kadia, T., Dinardo, C., Pierce, S., Huang, X., Pemmaraju, N., Diaz-Pines-Mateo, M., Cortes, J. & Borthakur, G., Feb 1 2016, In: Leukemia. 30, 2, p. 268-273 6 p.

  Research output: Contribution to journal › Article › peer-review
  59 Scopus citations

• A phase II study of induction chemotherapy followed by thoracic radiotherapy and erlotinib in poor-risk stage III non-small-cell lung cancer: Results of CALGB 30605 (Alliance)/RTOG 0972 (NRG)

  Lilenbaum, R., Samuels, M., Wang, X., Kong, F. M., Jänne, P. A., Masters, G., Katragadda, S., Hodgson, L., Bogart, J., Bradley, J. & Vokes, E., Jan 1 2015, In: Journal of Thoracic Oncology. 10, 1, p. 143-147 5 p.

  Research output: Contribution to journal › Article › peer-review
  42 Scopus citations

• A phase II study of lenalidomide alone in relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes with chromosome 5 abnormalities

  Chen, Y., Kantarjian, H., Estrov, Z., Faderl, S., Ravandi, F., Rey, K., Cortes, J. & Borthakur, G., Oct 2012, In: Clinical Lymphoma, Myeloma and Leukemia. 12, 5, p. 341-344 4 p.

  Research output: Contribution to journal › Article › peer-review
  28 Scopus citations

• A phase II study of mitoguazone and vinblastine in advanced transitional cell carcinoma of the urinary tract

  Barrett, J. T., Orofiamma, B., Khandekar, J. D., Carbone, P. P., Comis, R. L. & Davis, T. E., Dec 15 1989, In: Cancer. 64, 12, p. 2445-2447 3 p.

  Research output: Contribution to journal › Article › peer-review
  1 Scopus citations

• A phase II study of modulated-capecitabine and docetaxel in chemonaive patients with advanced non-small cell lung cancer (NSCLC)

  Bertino, E. M., Bekaii-Saab, T., Fernandez, S., Diasio, R. B., Karim, N. A., Otterson, G. A. & Villalona-Calero, M. A., Jan 2013, In: Lung Cancer. 79, 1, p. 27-32 6 p.

  Research output: Contribution to journal › Article › peer-review
  5 Scopus citations

• A phase II study of weekly paclitaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer

  Kallab, A. M., Nalamolu, Y., Dainer, P. M. & Jillella, A. P., Jun 2005, In: Medical Oncology. 22, 2, p. 145-151 7 p.

  Research output: Contribution to journal › Article › peer-review
  6 Scopus citations

• A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms

  Assi, R., Kantarjian, H. M., Garcia-Manero, G., Cortes, J. E., Pemmaraju, N., Wang, X., Nogueras-Gonzalez, G., Jabbour, E., Bose, P., Kadia, T., Dinardo, C. D., Patel, K., Bueso-Ramos, C., Zhou, L., Pierce, S., Gergis, R., Tuttle, C., Borthakur, G., Estrov, Z., Luthra, R., & 3 othersHidalgo-Lopez, J., Verstovsek, S. & Daver, N., Feb 2018, In: American Journal of Hematology. 93, 2, p. 277-285 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  45 Scopus citations

• A phase I randomized study of subcutaneous adjuvant IL-2 in combination with an autologous tumor vaccine in patients with advanced renal cell carcinoma

  Fenton, R. G., Steis, R. G., Madara, K., Zea, A. H., Ochoa, A. C., Janik, J. E., Smith, J. W., Gause, B. L., Sharfman, W. H., Urba, W. J., Hanna, M. G., DeJager, R. L., Coyne, M. X., Crouch, R. D., Gray, P., Beveridge, J., Creekmore, S. P., Holmlund, J., Curti, B. D., Sznol, M., & 1 othersLongo, D. L., 1996, In: Journal of Immunotherapy. 19, 5, p. 364-374 11 p.

  Research output: Contribution to journal › Article › peer-review
  18 Scopus citations

• A phase I study of danusertib (PHA-739358) in adult patients with accelerated or blastic phase chronic myeloid leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia resistant or intolerant to imatinib and/or other second generation c-ABL therapy

  Borthakur, G., Dombret, H., Schafhausen, P., Brummendorf, T. H., Boisse, N., Jabbour, E., Mariani, M., Capolongo, L., Carpinelli, P., Davite, C., Kantarjian, H. & Cortes, J. E., Jul 6 2015, In: Haematologica. 100, 7, p. 898-904 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  44 Scopus citations

• A phase I study of idarubicin dose escalation with amifostine and high-dose cytarabine in patients with relapsed acute myelogenous leukemia and myelodysplastic syndromes

  Garcia-Manero, G., Faderl, S., Giles, F., Thomas, D., Cortes, J., O'Brien, S., Davis, J., Kantarjian, H. M. & Estey, E., Jan 1 2002, In: Haematologica. 87, 8, p. 804-807 4 p.

  Research output: Contribution to journal › Article › peer-review
  7 Scopus citations

• A phase I study of intravenous LBH589, a novel cinnamic hydroxamic acid analogue histone deacetylase inhibitor, in patients with refractory hematologic malignancies

  Giles, F., Fischer, T., Cortes, J., Garcia-Manero, G., Beck, J., Ravandi, F., Masson, E., Rae, P., Laird, G., Sharma, S., Kantarjian, H., Dugan, M., Albitar, M. & Bhalla, K., Aug 1 2006, In: Clinical Cancer Research. 12, 15, p. 4628-4635 8 p.

  Research output: Contribution to journal › Article › peer-review
  307 Scopus citations

• A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia

  Short, N. J., Kantarjian, H., Jabbour, E., Cortes, J. E., Thomas, D. A., Rytting, M. E., Daver, N., Alvarado, Y., Konopleva, M., Kebriaei, P., Wierda, W. G., DiNardo, C. D., Bivins, C., McCue, D., Richie, M. A. & Ravandi, F., Aug 2018, In: British Journal of Haematology. 182, 3, p. 442-444 3 p.

  Research output: Contribution to journal › Letter › peer-review
  9 Scopus citations

• A phase I trial of an HLA-A1 restricted MAGE-3 epitope peptide with incomplete freund’s adjuvant in patients with resected high-risk melanoma

  Weber, J. S., Hua, F. L., Spears, L., Marty, V., Kuniyoshi, C. & Celis, E., 1999, In: Journal of Immunotherapy. 22, 5, p. 431-440 10 p.

  Research output: Contribution to journal › Article › peer-review
  118 Scopus citations

• A Phase I Trial to Determine the Safety and Tolerability of Autophagy Inhibition Using Chloroquine or Hydroxychloroquine in Combination With Carboplatin and Gemcitabine in Patients With Advanced Solid Tumors

  Karim, N. A., Ullah, A., Ahmad, I., Bahassi, E., Olowokure, O., Khaled, A., Davis, H. & Morris, J. C., Apr 26 2022, In: Frontiers in Oncology. 12, 811411.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  1 Scopus citations

• A phase I vaccine trial with peptides reflecting ras oncogene mutations of solid tumors

  Khleif, S. N., Abrams, S. I., Hamilton, J. M., Bergmann-Leitner, E., Chen, A., Bastian, A., Bernstein, S., Chung, Y., Allegra, C. J. & Schlom, J., Jan 1 1999, In: Journal of Immunotherapy. 22, 2, p. 155-165 11 p.

  Research output: Contribution to journal › Article › peer-review
  104 Scopus citations

• A Phenomenological Inquiry of the Perceptions of Simulation among ADN Students with Prior Health Care Experience

  Miller, B. A., Kimble, L. P., Sudia, T. & Gee, R. M., Oct 1 2016, In: Teaching and Learning in Nursing. 11, 4, p. 189-193 5 p.

  Research output: Contribution to journal › Article › peer-review
  3 Scopus citations

• A photoactivable source of relaxing factor in genetic hypertension

  Charpie, J. R., Peters, A. & Webb, R. C., Jun 1994, In: Hypertension. 23, 6, p. 894-898 5 p.

  Research output: Contribution to journal › Article › peer-review
  14 Scopus citations

• A photographic representation of the variability in the G-banded structure of the chromosomes in the mouse karyotype - A guide to the identification of the individual chromosomes

  Cowell, J. K., Apr 1 1984, In: Chromosoma. 89, 4, p. 294-320 27 p.

  Research output: Contribution to journal › Article › peer-review
  92 Scopus citations